Serum Institute to start manufacturing Sputnik vaccine in September
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
US FDA adds new warning on J&J COVID-19 vaccine for Guillain-Barre´ syndrome
It said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations,…
Shortage of Sputnik V’s second dose to delay India’s full roll out, says Dr…
Dr Reddy's had received about three million first doses by 1st June and about 360,000 doses of the second by early this month, the…
Abbott launches Panbio COVID-19 Antigen Self-Test in India
The self-test features a minimally invasive nasal swab and delivers results in as early as15 minutes with no instrumentation
Moderna signs supply pact with Argentina for 20 million doses of its COVID-19 vaccine
Delivery to begin in the first quarter of 2022
SINOVAC signs agreement to supply CoronaVac to COVAX
SINOVAC will supply 50 million doses of CoronaVac by the end of September 2021
Study finds nasal COVID-19 vaccine blocks transmission, prevents disease in animals
The researchers noted that the vaccine only requires a single dose and it may be stored at normal refrigerator temperatures for up…
WHO is likely to decide on EUL of Covaxin in four to six weeks
According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during…
ICMR proposes clinical trial along with Oxford University to evaluate COVID-19 therapy
The trial -- 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)'-- will be a multi-centre, adaptive platform trial on…
Study notes COVID-19 most likely caused by animal source, not of lab origin
The study noted that while a laboratory accident "cannot be entirely dismissed", there currently exists zero evidence for such a…
Working with Moderna to see make its COVID vaccine available in India: Govt
Moderna's COVID-19 vaccine was granted emergency use authorisation last month
Striving to increase vaccine availability through imports: Govt
MEA Spokesperson Arindam Bagchi said India hopes that individual countries would increasingly recognise made-in-India vaccines
Mankind Pharma gets DRDO nod to make and market 2-DG
The company will manufacture the product at its facilities in Visakhapatnam and Himachal Pradesh
Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus…
Regulatory issues cause delay in COVID-19 supplies to India from US
Last month, the US pledged to ship 80 million doses of American made COVID-19 vaccines to countries around the world and India…
Research finds mutations aid Epsilon coronavirus variant evade protection from vaccines
The mutations also provide the variant of concern named CAL.20C a means to totally evade specific monoclonal or lab-made…
Protein spikes developed in labs consistent with COVID-19 virus
The manufacture of protein "spikes" is key to designing serological tests and vaccines against COVID-19
Israel reports decrease in Pfizer vaccine effectiveness against infections
The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
The first batch will be shipped to the Gamaleya Center for the quality control
ICMR-NICED submits proposal to DBT for research on oral COVID-19 vaccine
It will take around five to six years to develop the oral vaccine in a laboratory, said Shanta Dutta, Director, ICMR-NICED